Skip to content

Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518376-31-00
Acronym
1INSULINAOJOSECO2021
Enrollment
120
Registered
2024-10-18
Start date
2022-10-19
Completion date
2025-11-05
Last updated
2024-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye disease

Brief summary

Change of corneal staining from baseline to 6 months after treatment

Detailed description

Changes in dry eye symptoms from baseline to 6 months after treatment time, Changes in esthesiometry from baseline to 6 months after treatment time, Changes in tear rupture time from baseline to 6 months after treatment time, Chnges in conjunctival hyperemia from baseline to 6 months of treatment, Proportion of patients presenting adverse effects

Interventions

Sponsors

Hospital Clinico San Carlos
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Change of corneal staining from baseline to 6 months after treatment

Secondary

MeasureTime frame
Changes in dry eye symptoms from baseline to 6 months after treatment time, Changes in esthesiometry from baseline to 6 months after treatment time, Changes in tear rupture time from baseline to 6 months after treatment time, Chnges in conjunctival hyperemia from baseline to 6 months of treatment, Proportion of patients presenting adverse effects

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026